ArticleScientific reports2026
Sesquiterpene lactones in micropropagated Arnica montana shoots after elicitation-insights into metabolite accumulation and transcriptional regulation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Sesquiterpene lactones (STLs) are important secondary metabolites synthesized in the aerial parts of Arnica montana L. The accumulation of STLs in micropropagated shoots treated with yeast extract (YE), salicylic acid (SA) and methyl jasmonate (MeJA) was measured by HPLC, while qualitative analysis was performed using HPLC-DAD-ESI-MS. YE (100 mg/L) and SA (200 µM) applied separately increased the total STL content by nearly 4.5-fold and 3-fold, respectively, compared to the control. The shoots treated with MeJA displayed the least pronounced changes in STL levels. The RT-qPCR analysis revealed a similar pattern of expression in both YE- and SA-treated shoots, characterized by strong upregulation of key genes (GAS and GAO) involved in the final steps of STL biosynthesis. YE elicitation resulted also in increased transcription of FDS, which provides the universal C15 precursor for sesquiterpenes. SA treatment led to the induction of HMGCR—encoding a key rate-limiting enzyme in the mevalonate pathway. Although MeJA also led to upregulation of both HMGCR and FDS, the effect of this elicitor was minimal. None of the treatments affected the expression of genes associated with the MEP/DOXP pathway (DXS and DXR). These findings provide valuable insights for future investigations into molecular mechanisms regulating STLs biosynthesis in A. montana.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.